nodes	percent_of_prediction	percent_of_DWPC	metapath
Pirbuterol—ADRB1—Bromocriptine—type 2 diabetes mellitus	0.369	1	CbGbCtD
Pirbuterol—Nadolol—ADRB3—type 2 diabetes mellitus	0.0034	0.208	CrCbGaD
Pirbuterol—Clenbuterol—ADRB3—type 2 diabetes mellitus	0.00328	0.201	CrCbGaD
Pirbuterol—Bupranolol—ADRB3—type 2 diabetes mellitus	0.00325	0.199	CrCbGaD
Pirbuterol—Clenbuterol—TNF—type 2 diabetes mellitus	0.00141	0.0863	CrCbGaD
Pirbuterol—Epinephrine—ADRB3—type 2 diabetes mellitus	0.00138	0.0845	CrCbGaD
Pirbuterol—Clenbuterol—CYP1A2—type 2 diabetes mellitus	0.00103	0.0632	CrCbGaD
Pirbuterol—Pruritus—Glipizide—type 2 diabetes mellitus	0.00082	0.00177	CcSEcCtD
Pirbuterol—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.000817	0.00176	CcSEcCtD
Pirbuterol—Weight increased—Ramipril—type 2 diabetes mellitus	0.000816	0.00176	CcSEcCtD
Pirbuterol—Syncope—Valsartan—type 2 diabetes mellitus	0.000808	0.00174	CcSEcCtD
Pirbuterol—Confusional state—Gliclazide—type 2 diabetes mellitus	0.000807	0.00174	CcSEcCtD
Pirbuterol—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000804	0.00173	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000798	0.00172	CcSEcCtD
Pirbuterol—Palpitations—Valsartan—type 2 diabetes mellitus	0.000797	0.00172	CcSEcCtD
Pirbuterol—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000796	0.00172	CcSEcCtD
Pirbuterol—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000793	0.00171	CcSEcCtD
Pirbuterol—Loss of consciousness—Valsartan—type 2 diabetes mellitus	0.000792	0.00171	CcSEcCtD
Pirbuterol—Muscle spasms—Metformin—type 2 diabetes mellitus	0.000789	0.0017	CcSEcCtD
Pirbuterol—Palpitations—Orlistat—type 2 diabetes mellitus	0.000787	0.0017	CcSEcCtD
Pirbuterol—Cough—Valsartan—type 2 diabetes mellitus	0.000787	0.0017	CcSEcCtD
Pirbuterol—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000786	0.0017	CcSEcCtD
Pirbuterol—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.000781	0.00169	CcSEcCtD
Pirbuterol—Stomatitis—Ramipril—type 2 diabetes mellitus	0.00078	0.00168	CcSEcCtD
Pirbuterol—Cough—Orlistat—type 2 diabetes mellitus	0.000777	0.00168	CcSEcCtD
Pirbuterol—Flushing—Losartan—type 2 diabetes mellitus	0.000777	0.00168	CcSEcCtD
Pirbuterol—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000776	0.00167	CcSEcCtD
Pirbuterol—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000775	0.00167	CcSEcCtD
Pirbuterol—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000773	0.00167	CcSEcCtD
Pirbuterol—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000771	0.00166	CcSEcCtD
Pirbuterol—Tremor—Metformin—type 2 diabetes mellitus	0.000769	0.00166	CcSEcCtD
Pirbuterol—Chest pain—Valsartan—type 2 diabetes mellitus	0.000767	0.00166	CcSEcCtD
Pirbuterol—Dizziness—Glipizide—type 2 diabetes mellitus	0.000766	0.00165	CcSEcCtD
Pirbuterol—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000765	0.00165	CcSEcCtD
Pirbuterol—Anxiety—Valsartan—type 2 diabetes mellitus	0.000765	0.00165	CcSEcCtD
Pirbuterol—Tension—Irbesartan—type 2 diabetes mellitus	0.00076	0.00164	CcSEcCtD
Pirbuterol—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000759	0.00164	CcSEcCtD
Pirbuterol—Chest pain—Orlistat—type 2 diabetes mellitus	0.000758	0.00164	CcSEcCtD
Pirbuterol—Anxiety—Orlistat—type 2 diabetes mellitus	0.000756	0.00163	CcSEcCtD
Pirbuterol—Nervousness—Irbesartan—type 2 diabetes mellitus	0.000752	0.00162	CcSEcCtD
Pirbuterol—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000751	0.00162	CcSEcCtD
Pirbuterol—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000748	0.00161	CcSEcCtD
Pirbuterol—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.000745	0.00161	CcSEcCtD
Pirbuterol—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000742	0.0016	CcSEcCtD
Pirbuterol—Alopecia—Losartan—type 2 diabetes mellitus	0.00074	0.0016	CcSEcCtD
Pirbuterol—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.00074	0.0016	CcSEcCtD
Pirbuterol—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000737	0.00159	CcSEcCtD
Pirbuterol—Vomiting—Glipizide—type 2 diabetes mellitus	0.000737	0.00159	CcSEcCtD
Pirbuterol—Syncope—Metformin—type 2 diabetes mellitus	0.000736	0.00159	CcSEcCtD
Pirbuterol—Oedema—Valsartan—type 2 diabetes mellitus	0.000736	0.00159	CcSEcCtD
Pirbuterol—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000735	0.00159	CcSEcCtD
Pirbuterol—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000734	0.00158	CcSEcCtD
Pirbuterol—Rash—Glipizide—type 2 diabetes mellitus	0.000731	0.00158	CcSEcCtD
Pirbuterol—Dermatitis—Glipizide—type 2 diabetes mellitus	0.00073	0.00158	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000729	0.00157	CcSEcCtD
Pirbuterol—Oedema—Orlistat—type 2 diabetes mellitus	0.000727	0.00157	CcSEcCtD
Pirbuterol—Headache—Glipizide—type 2 diabetes mellitus	0.000726	0.00157	CcSEcCtD
Pirbuterol—Tremor—Irbesartan—type 2 diabetes mellitus	0.000726	0.00157	CcSEcCtD
Pirbuterol—Palpitations—Metformin—type 2 diabetes mellitus	0.000725	0.00157	CcSEcCtD
Pirbuterol—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000724	0.00156	CcSEcCtD
Pirbuterol—Shock—Valsartan—type 2 diabetes mellitus	0.000724	0.00156	CcSEcCtD
Pirbuterol—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000721	0.00156	CcSEcCtD
Pirbuterol—Tension—Losartan—type 2 diabetes mellitus	0.000715	0.00154	CcSEcCtD
Pirbuterol—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000715	0.00154	CcSEcCtD
Pirbuterol—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000713	0.00154	CcSEcCtD
Pirbuterol—Agitation—Irbesartan—type 2 diabetes mellitus	0.000712	0.00154	CcSEcCtD
Pirbuterol—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000712	0.00154	CcSEcCtD
Pirbuterol—Nervousness—Losartan—type 2 diabetes mellitus	0.000708	0.00153	CcSEcCtD
Pirbuterol—Back pain—Losartan—type 2 diabetes mellitus	0.000705	0.00152	CcSEcCtD
Pirbuterol—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000705	0.00152	CcSEcCtD
Pirbuterol—Anorexia—Valsartan—type 2 diabetes mellitus	0.000701	0.00151	CcSEcCtD
Pirbuterol—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000701	0.00151	CcSEcCtD
Pirbuterol—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.0007	0.00151	CcSEcCtD
Pirbuterol—Chest pain—Metformin—type 2 diabetes mellitus	0.000699	0.00151	CcSEcCtD
Pirbuterol—Headache—Pioglitazone—type 2 diabetes mellitus	0.000695	0.0015	CcSEcCtD
Pirbuterol—Syncope—Irbesartan—type 2 diabetes mellitus	0.000695	0.0015	CcSEcCtD
Pirbuterol—Fatigue—Gliclazide—type 2 diabetes mellitus	0.00069	0.00149	CcSEcCtD
Pirbuterol—Nausea—Glipizide—type 2 diabetes mellitus	0.000688	0.00149	CcSEcCtD
Pirbuterol—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000687	0.00148	CcSEcCtD
Pirbuterol—Hypotension—Valsartan—type 2 diabetes mellitus	0.000687	0.00148	CcSEcCtD
Pirbuterol—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000685	0.00148	CcSEcCtD
Pirbuterol—Tremor—Losartan—type 2 diabetes mellitus	0.000683	0.00147	CcSEcCtD
Pirbuterol—Rash—Glimepiride—type 2 diabetes mellitus	0.000682	0.00147	CcSEcCtD
Pirbuterol—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000681	0.00147	CcSEcCtD
Pirbuterol—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000681	0.00147	CcSEcCtD
Pirbuterol—Rash—Sitagliptin—type 2 diabetes mellitus	0.00068	0.00147	CcSEcCtD
Pirbuterol—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000679	0.00147	CcSEcCtD
Pirbuterol—Headache—Glimepiride—type 2 diabetes mellitus	0.000677	0.00146	CcSEcCtD
Pirbuterol—Cough—Irbesartan—type 2 diabetes mellitus	0.000676	0.00146	CcSEcCtD
Pirbuterol—Headache—Sitagliptin—type 2 diabetes mellitus	0.000675	0.00146	CcSEcCtD
Pirbuterol—Agitation—Losartan—type 2 diabetes mellitus	0.00067	0.00145	CcSEcCtD
Pirbuterol—Oedema—Metformin—type 2 diabetes mellitus	0.00067	0.00145	CcSEcCtD
Pirbuterol—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000667	0.00144	CcSEcCtD
Pirbuterol—Flushing—Ramipril—type 2 diabetes mellitus	0.000666	0.00144	CcSEcCtD
Pirbuterol—Insomnia—Valsartan—type 2 diabetes mellitus	0.000665	0.00144	CcSEcCtD
Pirbuterol—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.00066	0.00142	CcSEcCtD
Pirbuterol—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000659	0.00142	CcSEcCtD
Pirbuterol—Shock—Metformin—type 2 diabetes mellitus	0.000659	0.00142	CcSEcCtD
Pirbuterol—Insomnia—Orlistat—type 2 diabetes mellitus	0.000657	0.00142	CcSEcCtD
Pirbuterol—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000657	0.00142	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000655	0.00141	CcSEcCtD
Pirbuterol—Somnolence—Valsartan—type 2 diabetes mellitus	0.000654	0.00141	CcSEcCtD
Pirbuterol—Syncope—Losartan—type 2 diabetes mellitus	0.000654	0.00141	CcSEcCtD
Pirbuterol—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000645	0.00139	CcSEcCtD
Pirbuterol—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000645	0.00139	CcSEcCtD
Pirbuterol—Palpitations—Losartan—type 2 diabetes mellitus	0.000644	0.00139	CcSEcCtD
Pirbuterol—Nausea—Glimepiride—type 2 diabetes mellitus	0.000642	0.00139	CcSEcCtD
Pirbuterol—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000641	0.00138	CcSEcCtD
Pirbuterol—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00064	0.00138	CcSEcCtD
Pirbuterol—Asthenia—Glyburide—type 2 diabetes mellitus	0.00064	0.00138	CcSEcCtD
Pirbuterol—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000639	0.00138	CcSEcCtD
Pirbuterol—Anorexia—Metformin—type 2 diabetes mellitus	0.000639	0.00138	CcSEcCtD
Pirbuterol—Cough—Losartan—type 2 diabetes mellitus	0.000636	0.00137	CcSEcCtD
Pirbuterol—Salbutamol—CYP3A4—type 2 diabetes mellitus	0.000635	0.0389	CrCbGaD
Pirbuterol—Alopecia—Ramipril—type 2 diabetes mellitus	0.000635	0.00137	CcSEcCtD
Pirbuterol—Fatigue—Valsartan—type 2 diabetes mellitus	0.000634	0.00137	CcSEcCtD
Pirbuterol—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000633	0.00137	CcSEcCtD
Pirbuterol—Oedema—Irbesartan—type 2 diabetes mellitus	0.000632	0.00136	CcSEcCtD
Pirbuterol—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000632	0.00136	CcSEcCtD
Pirbuterol—Pruritus—Glyburide—type 2 diabetes mellitus	0.000631	0.00136	CcSEcCtD
Pirbuterol—Fatigue—Orlistat—type 2 diabetes mellitus	0.000627	0.00135	CcSEcCtD
Pirbuterol—Hypotension—Metformin—type 2 diabetes mellitus	0.000626	0.00135	CcSEcCtD
Pirbuterol—Epinephrine—ADRA2A—type 2 diabetes mellitus	0.000624	0.0382	CrCbGaD
Pirbuterol—Shock—Irbesartan—type 2 diabetes mellitus	0.000622	0.00134	CcSEcCtD
Pirbuterol—Chest pain—Losartan—type 2 diabetes mellitus	0.000621	0.00134	CcSEcCtD
Pirbuterol—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.00062	0.00134	CcSEcCtD
Pirbuterol—Anxiety—Losartan—type 2 diabetes mellitus	0.000618	0.00133	CcSEcCtD
Pirbuterol—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000617	0.00133	CcSEcCtD
Pirbuterol—Rash—Bromocriptine—type 2 diabetes mellitus	0.000615	0.00133	CcSEcCtD
Pirbuterol—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000614	0.00133	CcSEcCtD
Pirbuterol—Tension—Ramipril—type 2 diabetes mellitus	0.000613	0.00132	CcSEcCtD
Pirbuterol—Headache—Bromocriptine—type 2 diabetes mellitus	0.000611	0.00132	CcSEcCtD
Pirbuterol—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.00061	0.00132	CcSEcCtD
Pirbuterol—Nervousness—Ramipril—type 2 diabetes mellitus	0.000607	0.00131	CcSEcCtD
Pirbuterol—Dry mouth—Losartan—type 2 diabetes mellitus	0.000607	0.00131	CcSEcCtD
Pirbuterol—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000603	0.0013	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000602	0.0013	CcSEcCtD
Pirbuterol—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000601	0.0013	CcSEcCtD
Pirbuterol—Confusional state—Losartan—type 2 diabetes mellitus	0.0006	0.00129	CcSEcCtD
Pirbuterol—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000599	0.00129	CcSEcCtD
Pirbuterol—Somnolence—Metformin—type 2 diabetes mellitus	0.000596	0.00129	CcSEcCtD
Pirbuterol—Oedema—Losartan—type 2 diabetes mellitus	0.000595	0.00128	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000594	0.00128	CcSEcCtD
Pirbuterol—Epinephrine—TNF—type 2 diabetes mellitus	0.000592	0.0362	CrCbGaD
Pirbuterol—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000591	0.00127	CcSEcCtD
Pirbuterol—Tremor—Ramipril—type 2 diabetes mellitus	0.000586	0.00126	CcSEcCtD
Pirbuterol—Shock—Losartan—type 2 diabetes mellitus	0.000585	0.00126	CcSEcCtD
Pirbuterol—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000582	0.00126	CcSEcCtD
Pirbuterol—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000582	0.00125	CcSEcCtD
Pirbuterol—Tachycardia—Losartan—type 2 diabetes mellitus	0.000581	0.00125	CcSEcCtD
Pirbuterol—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000579	0.00125	CcSEcCtD
Pirbuterol—Fatigue—Metformin—type 2 diabetes mellitus	0.000578	0.00125	CcSEcCtD
Pirbuterol—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000575	0.00124	CcSEcCtD
Pirbuterol—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000574	0.00124	CcSEcCtD
Pirbuterol—Agitation—Ramipril—type 2 diabetes mellitus	0.000574	0.00124	CcSEcCtD
Pirbuterol—Anorexia—Losartan—type 2 diabetes mellitus	0.000567	0.00122	CcSEcCtD
Pirbuterol—Vomiting—Glyburide—type 2 diabetes mellitus	0.000567	0.00122	CcSEcCtD
Pirbuterol—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000566	0.00122	CcSEcCtD
Pirbuterol—Rash—Glyburide—type 2 diabetes mellitus	0.000562	0.00121	CcSEcCtD
Pirbuterol—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000562	0.00121	CcSEcCtD
Pirbuterol—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000562	0.00121	CcSEcCtD
Pirbuterol—Syncope—Ramipril—type 2 diabetes mellitus	0.000561	0.00121	CcSEcCtD
Pirbuterol—Headache—Glyburide—type 2 diabetes mellitus	0.000559	0.00121	CcSEcCtD
Pirbuterol—Hypotension—Losartan—type 2 diabetes mellitus	0.000556	0.0012	CcSEcCtD
Pirbuterol—Palpitations—Ramipril—type 2 diabetes mellitus	0.000552	0.00119	CcSEcCtD
Pirbuterol—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000552	0.00119	CcSEcCtD
Pirbuterol—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.00055	0.00119	CcSEcCtD
Pirbuterol—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000549	0.00119	CcSEcCtD
Pirbuterol—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000548	0.00118	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000548	0.00118	CcSEcCtD
Pirbuterol—Cough—Ramipril—type 2 diabetes mellitus	0.000545	0.00118	CcSEcCtD
Pirbuterol—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000545	0.00118	CcSEcCtD
Pirbuterol—Insomnia—Losartan—type 2 diabetes mellitus	0.000538	0.00116	CcSEcCtD
Pirbuterol—Chest pain—Ramipril—type 2 diabetes mellitus	0.000532	0.00115	CcSEcCtD
Pirbuterol—Anxiety—Ramipril—type 2 diabetes mellitus	0.00053	0.00114	CcSEcCtD
Pirbuterol—Nausea—Glyburide—type 2 diabetes mellitus	0.00053	0.00114	CcSEcCtD
Pirbuterol—Abdominal pain—Metformin—type 2 diabetes mellitus	0.00053	0.00114	CcSEcCtD
Pirbuterol—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000529	0.00114	CcSEcCtD
Pirbuterol—Somnolence—Losartan—type 2 diabetes mellitus	0.000529	0.00114	CcSEcCtD
Pirbuterol—Asthenia—Valsartan—type 2 diabetes mellitus	0.000528	0.00114	CcSEcCtD
Pirbuterol—Asthenia—Orlistat—type 2 diabetes mellitus	0.000522	0.00113	CcSEcCtD
Pirbuterol—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000521	0.00112	CcSEcCtD
Pirbuterol—Pruritus—Valsartan—type 2 diabetes mellitus	0.00052	0.00112	CcSEcCtD
Pirbuterol—Dry mouth—Ramipril—type 2 diabetes mellitus	0.00052	0.00112	CcSEcCtD
Pirbuterol—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000517	0.00112	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000517	0.00112	CcSEcCtD
Pirbuterol—Confusional state—Ramipril—type 2 diabetes mellitus	0.000514	0.00111	CcSEcCtD
Pirbuterol—Pruritus—Orlistat—type 2 diabetes mellitus	0.000514	0.00111	CcSEcCtD
Pirbuterol—Fatigue—Losartan—type 2 diabetes mellitus	0.000513	0.00111	CcSEcCtD
Pirbuterol—Oedema—Ramipril—type 2 diabetes mellitus	0.00051	0.0011	CcSEcCtD
Pirbuterol—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000509	0.0011	CcSEcCtD
Pirbuterol—Rash—Gliclazide—type 2 diabetes mellitus	0.000505	0.00109	CcSEcCtD
Pirbuterol—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000504	0.00109	CcSEcCtD
Pirbuterol—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000503	0.00109	CcSEcCtD
Pirbuterol—Shock—Ramipril—type 2 diabetes mellitus	0.000502	0.00108	CcSEcCtD
Pirbuterol—Headache—Gliclazide—type 2 diabetes mellitus	0.000502	0.00108	CcSEcCtD
Pirbuterol—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.0005	0.00108	CcSEcCtD
Pirbuterol—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000498	0.00107	CcSEcCtD
Pirbuterol—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000497	0.00107	CcSEcCtD
Pirbuterol—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.00049	0.00106	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000487	0.00105	CcSEcCtD
Pirbuterol—Dizziness—Valsartan—type 2 diabetes mellitus	0.000486	0.00105	CcSEcCtD
Pirbuterol—Anorexia—Ramipril—type 2 diabetes mellitus	0.000486	0.00105	CcSEcCtD
Pirbuterol—Dizziness—Orlistat—type 2 diabetes mellitus	0.000481	0.00104	CcSEcCtD
Pirbuterol—Asthenia—Metformin—type 2 diabetes mellitus	0.000481	0.00104	CcSEcCtD
Pirbuterol—Hypotension—Ramipril—type 2 diabetes mellitus	0.000477	0.00103	CcSEcCtD
Pirbuterol—Nausea—Gliclazide—type 2 diabetes mellitus	0.000476	0.00103	CcSEcCtD
Pirbuterol—Pruritus—Metformin—type 2 diabetes mellitus	0.000474	0.00102	CcSEcCtD
Pirbuterol—Abdominal pain—Losartan—type 2 diabetes mellitus	0.00047	0.00101	CcSEcCtD
Pirbuterol—Vomiting—Valsartan—type 2 diabetes mellitus	0.000468	0.00101	CcSEcCtD
Pirbuterol—Rash—Valsartan—type 2 diabetes mellitus	0.000464	0.001	CcSEcCtD
Pirbuterol—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000463	0.001	CcSEcCtD
Pirbuterol—Vomiting—Orlistat—type 2 diabetes mellitus	0.000462	0.000997	CcSEcCtD
Pirbuterol—Insomnia—Ramipril—type 2 diabetes mellitus	0.000461	0.000996	CcSEcCtD
Pirbuterol—Headache—Valsartan—type 2 diabetes mellitus	0.000461	0.000995	CcSEcCtD
Pirbuterol—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000458	0.000989	CcSEcCtD
Pirbuterol—Rash—Orlistat—type 2 diabetes mellitus	0.000458	0.000989	CcSEcCtD
Pirbuterol—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000458	0.000988	CcSEcCtD
Pirbuterol—Headache—Orlistat—type 2 diabetes mellitus	0.000455	0.000983	CcSEcCtD
Pirbuterol—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000454	0.000979	CcSEcCtD
Pirbuterol—Somnolence—Ramipril—type 2 diabetes mellitus	0.000454	0.000979	CcSEcCtD
Pirbuterol—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000447	0.000965	CcSEcCtD
Pirbuterol—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000443	0.000957	CcSEcCtD
Pirbuterol—Dizziness—Metformin—type 2 diabetes mellitus	0.000443	0.000956	CcSEcCtD
Pirbuterol—Fatigue—Ramipril—type 2 diabetes mellitus	0.00044	0.000949	CcSEcCtD
Pirbuterol—Nausea—Valsartan—type 2 diabetes mellitus	0.000437	0.000943	CcSEcCtD
Pirbuterol—Epinephrine—CYP1A2—type 2 diabetes mellitus	0.000434	0.0266	CrCbGaD
Pirbuterol—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000433	0.000933	CcSEcCtD
Pirbuterol—Nausea—Orlistat—type 2 diabetes mellitus	0.000432	0.000932	CcSEcCtD
Pirbuterol—Asthenia—Losartan—type 2 diabetes mellitus	0.000427	0.000921	CcSEcCtD
Pirbuterol—Vomiting—Metformin—type 2 diabetes mellitus	0.000426	0.000919	CcSEcCtD
Pirbuterol—Rash—Metformin—type 2 diabetes mellitus	0.000422	0.000912	CcSEcCtD
Pirbuterol—Dermatitis—Metformin—type 2 diabetes mellitus	0.000422	0.000911	CcSEcCtD
Pirbuterol—Pruritus—Losartan—type 2 diabetes mellitus	0.000421	0.000908	CcSEcCtD
Pirbuterol—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.00042	0.000907	CcSEcCtD
Pirbuterol—Headache—Metformin—type 2 diabetes mellitus	0.00042	0.000906	CcSEcCtD
Pirbuterol—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000418	0.000902	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000417	0.0009	CcSEcCtD
Pirbuterol—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000407	0.000878	CcSEcCtD
Pirbuterol—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000403	0.00087	CcSEcCtD
Pirbuterol—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000402	0.000867	CcSEcCtD
Pirbuterol—Rash—Irbesartan—type 2 diabetes mellitus	0.000399	0.00086	CcSEcCtD
Pirbuterol—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000398	0.000859	CcSEcCtD
Pirbuterol—Nausea—Metformin—type 2 diabetes mellitus	0.000398	0.000859	CcSEcCtD
Pirbuterol—Headache—Irbesartan—type 2 diabetes mellitus	0.000396	0.000855	CcSEcCtD
Pirbuterol—Dizziness—Losartan—type 2 diabetes mellitus	0.000393	0.000849	CcSEcCtD
Pirbuterol—Vomiting—Losartan—type 2 diabetes mellitus	0.000378	0.000816	CcSEcCtD
Pirbuterol—Nausea—Irbesartan—type 2 diabetes mellitus	0.000376	0.00081	CcSEcCtD
Pirbuterol—Rash—Losartan—type 2 diabetes mellitus	0.000375	0.00081	CcSEcCtD
Pirbuterol—Dermatitis—Losartan—type 2 diabetes mellitus	0.000375	0.000809	CcSEcCtD
Pirbuterol—Headache—Losartan—type 2 diabetes mellitus	0.000373	0.000804	CcSEcCtD
Pirbuterol—Asthenia—Ramipril—type 2 diabetes mellitus	0.000366	0.00079	CcSEcCtD
Pirbuterol—Pruritus—Ramipril—type 2 diabetes mellitus	0.000361	0.000779	CcSEcCtD
Pirbuterol—Nausea—Losartan—type 2 diabetes mellitus	0.000353	0.000763	CcSEcCtD
Pirbuterol—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000349	0.000753	CcSEcCtD
Pirbuterol—Dizziness—Ramipril—type 2 diabetes mellitus	0.000337	0.000728	CcSEcCtD
Pirbuterol—Vomiting—Ramipril—type 2 diabetes mellitus	0.000324	0.0007	CcSEcCtD
Pirbuterol—Rash—Ramipril—type 2 diabetes mellitus	0.000322	0.000694	CcSEcCtD
Pirbuterol—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000321	0.000694	CcSEcCtD
Pirbuterol—Headache—Ramipril—type 2 diabetes mellitus	0.00032	0.00069	CcSEcCtD
Pirbuterol—Nausea—Ramipril—type 2 diabetes mellitus	0.000303	0.000654	CcSEcCtD
Pirbuterol—Epinephrine—CYP3A4—type 2 diabetes mellitus	0.000287	0.0176	CrCbGaD
Pirbuterol—ADRB1—GPCR downstream signaling—AGTR2—type 2 diabetes mellitus	0.000121	0.000798	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR ligand binding—C3—type 2 diabetes mellitus	0.000119	0.000787	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—TRPC6—type 2 diabetes mellitus	0.000119	0.000786	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—AGTR2—type 2 diabetes mellitus	0.000118	0.000781	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—GIPR—type 2 diabetes mellitus	0.000117	0.000773	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—GRK5—type 2 diabetes mellitus	0.000117	0.000773	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—EDNRB—type 2 diabetes mellitus	0.000116	0.000765	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR ligand binding—AGT—type 2 diabetes mellitus	0.000116	0.000765	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—GIPR—type 2 diabetes mellitus	0.000115	0.000756	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—GRK5—type 2 diabetes mellitus	0.000115	0.000756	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—EDNRB—type 2 diabetes mellitus	0.000113	0.000748	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR ligand binding—AGT—type 2 diabetes mellitus	0.000113	0.000748	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—IAPP—type 2 diabetes mellitus	0.000113	0.000747	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—HTR2C—type 2 diabetes mellitus	0.000112	0.000742	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—IAPP—type 2 diabetes mellitus	0.000111	0.000731	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—TRPC6—type 2 diabetes mellitus	0.000111	0.000729	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—HTR2C—type 2 diabetes mellitus	0.00011	0.000726	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—AGTR2—type 2 diabetes mellitus	0.00011	0.000725	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—EDNRA—type 2 diabetes mellitus	0.000109	0.000722	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—TRPC6—type 2 diabetes mellitus	0.000108	0.000713	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—AGTR2—type 2 diabetes mellitus	0.000107	0.000709	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—MC4R—type 2 diabetes mellitus	0.000107	0.000707	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—ADRA2A—type 2 diabetes mellitus	0.000107	0.000707	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—EDNRA—type 2 diabetes mellitus	0.000107	0.000706	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—GHRL—type 2 diabetes mellitus	0.000107	0.000704	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—CALCA—type 2 diabetes mellitus	0.000105	0.000695	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—EDNRB—type 2 diabetes mellitus	0.000105	0.000694	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—MC4R—type 2 diabetes mellitus	0.000105	0.000692	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—ADRA2A—type 2 diabetes mellitus	0.000105	0.000691	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—GHRL—type 2 diabetes mellitus	0.000104	0.000688	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—GIP—type 2 diabetes mellitus	0.000103	0.000681	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—CALCA—type 2 diabetes mellitus	0.000103	0.00068	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—EDNRB—type 2 diabetes mellitus	0.000103	0.000679	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—HTR2C—type 2 diabetes mellitus	0.000102	0.000674	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—GIP—type 2 diabetes mellitus	0.000101	0.000666	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—HTR2C—type 2 diabetes mellitus	9.99e-05	0.000659	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—EDNRA—type 2 diabetes mellitus	9.94e-05	0.000656	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—LEPR—type 2 diabetes mellitus	9.8e-05	0.000647	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—GCG—type 2 diabetes mellitus	9.75e-05	0.000644	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	9.73e-05	0.000642	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—EDNRA—type 2 diabetes mellitus	9.72e-05	0.000641	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—GHRL—type 2 diabetes mellitus	9.68e-05	0.000639	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	9.6e-05	0.000633	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—LEPR—type 2 diabetes mellitus	9.59e-05	0.000633	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—CALCA—type 2 diabetes mellitus	9.57e-05	0.000631	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR ligand binding—CCL2—type 2 diabetes mellitus	9.54e-05	0.00063	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—GCG—type 2 diabetes mellitus	9.54e-05	0.00063	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	9.51e-05	0.000628	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—GHRL—type 2 diabetes mellitus	9.47e-05	0.000625	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	9.39e-05	0.000619	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	9.37e-05	0.000618	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—CALCA—type 2 diabetes mellitus	9.36e-05	0.000617	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR ligand binding—CCL2—type 2 diabetes mellitus	9.33e-05	0.000616	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	9.16e-05	0.000604	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—TLE4—type 2 diabetes mellitus	9.11e-05	0.000601	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—TLE4—type 2 diabetes mellitus	8.91e-05	0.000588	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—GCG—type 2 diabetes mellitus	8.86e-05	0.000584	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—ADRB3—type 2 diabetes mellitus	8.77e-05	0.000579	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	8.71e-05	0.000575	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—GCG—type 2 diabetes mellitus	8.66e-05	0.000572	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—ADRB3—type 2 diabetes mellitus	8.58e-05	0.000566	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	8.52e-05	0.000562	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CRHR1—type 2 diabetes mellitus	8.47e-05	0.000559	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	8.41e-05	0.000555	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—AVP—type 2 diabetes mellitus	8.29e-05	0.000547	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CRHR1—type 2 diabetes mellitus	8.29e-05	0.000547	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	8.22e-05	0.000543	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—AVP—type 2 diabetes mellitus	8.11e-05	0.000535	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	7.89e-05	0.000521	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	7.82e-05	0.000516	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—SPRY2—type 2 diabetes mellitus	7.75e-05	0.000511	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	7.75e-05	0.000511	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	7.72e-05	0.000509	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	7.65e-05	0.000504	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—GNB3—type 2 diabetes mellitus	7.63e-05	0.000504	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	7.58e-05	0.0005	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—SPRY2—type 2 diabetes mellitus	7.58e-05	0.0005	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—RBP4—type 2 diabetes mellitus	7.55e-05	0.000498	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—GLP1R—type 2 diabetes mellitus	7.55e-05	0.000498	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—MMP3—type 2 diabetes mellitus	7.53e-05	0.000497	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—AVP—type 2 diabetes mellitus	7.53e-05	0.000497	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	7.49e-05	0.000494	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—GNB3—type 2 diabetes mellitus	7.47e-05	0.000493	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CCKAR—type 2 diabetes mellitus	7.43e-05	0.00049	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—RBP4—type 2 diabetes mellitus	7.38e-05	0.000487	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—GLP1R—type 2 diabetes mellitus	7.38e-05	0.000487	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—AVP—type 2 diabetes mellitus	7.37e-05	0.000486	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—MMP3—type 2 diabetes mellitus	7.37e-05	0.000486	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	7.33e-05	0.000484	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CCKAR—type 2 diabetes mellitus	7.26e-05	0.000479	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—EDN1—type 2 diabetes mellitus	7.16e-05	0.000473	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	7.05e-05	0.000465	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—EDN1—type 2 diabetes mellitus	7.01e-05	0.000462	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	6.9e-05	0.000455	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—C3—type 2 diabetes mellitus	6.89e-05	0.000455	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	6.8e-05	0.000449	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—C3—type 2 diabetes mellitus	6.74e-05	0.000445	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	6.73e-05	0.000444	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—IAPP—type 2 diabetes mellitus	6.69e-05	0.000441	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	6.66e-05	0.000439	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—INSR—type 2 diabetes mellitus	6.65e-05	0.000439	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	6.58e-05	0.000434	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—AGT—type 2 diabetes mellitus	6.55e-05	0.000432	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—IAPP—type 2 diabetes mellitus	6.54e-05	0.000432	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	6.53e-05	0.000431	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	6.52e-05	0.00043	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—INSR—type 2 diabetes mellitus	6.5e-05	0.000429	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	6.49e-05	0.000428	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—AGT—type 2 diabetes mellitus	6.41e-05	0.000423	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—CCR5—type 2 diabetes mellitus	6.4e-05	0.000423	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—TRPC6—type 2 diabetes mellitus	6.39e-05	0.000421	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	6.38e-05	0.000421	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—AGTR2—type 2 diabetes mellitus	6.35e-05	0.000419	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—CCR5—type 2 diabetes mellitus	6.26e-05	0.000413	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—C3—type 2 diabetes mellitus	6.26e-05	0.000413	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	6.22e-05	0.00041	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—C3—type 2 diabetes mellitus	6.12e-05	0.000404	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—EDNRB—type 2 diabetes mellitus	6.08e-05	0.000401	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	6.05e-05	0.000399	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	6.03e-05	0.000398	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	6.03e-05	0.000398	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—AGT—type 2 diabetes mellitus	5.95e-05	0.000392	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	5.92e-05	0.000391	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—HTR2C—type 2 diabetes mellitus	5.9e-05	0.00039	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PSMD6—type 2 diabetes mellitus	5.9e-05	0.00039	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	5.87e-05	0.000387	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	5.85e-05	0.000386	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CYBA—type 2 diabetes mellitus	5.84e-05	0.000386	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—AGT—type 2 diabetes mellitus	5.82e-05	0.000384	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	5.74e-05	0.000379	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—EDNRA—type 2 diabetes mellitus	5.74e-05	0.000379	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—GHRL—type 2 diabetes mellitus	5.72e-05	0.000377	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PLAT—type 2 diabetes mellitus	5.72e-05	0.000377	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—CALM1—type 2 diabetes mellitus	5.72e-05	0.000377	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CYBA—type 2 diabetes mellitus	5.72e-05	0.000377	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CALCA—type 2 diabetes mellitus	5.65e-05	0.000373	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	5.62e-05	0.000371	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—GHRL—type 2 diabetes mellitus	5.6e-05	0.000369	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PLAT—type 2 diabetes mellitus	5.6e-05	0.000369	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CALCA—type 2 diabetes mellitus	5.53e-05	0.000365	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	5.49e-05	0.000363	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	5.37e-05	0.000355	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	5.32e-05	0.000351	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	5.3e-05	0.00035	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—GCG—type 2 diabetes mellitus	5.23e-05	0.000345	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	5.23e-05	0.000345	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	5.21e-05	0.000344	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	5.18e-05	0.000342	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	5.15e-05	0.00034	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	5.13e-05	0.000339	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	5.12e-05	0.000338	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—GCG—type 2 diabetes mellitus	5.12e-05	0.000338	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	5.04e-05	0.000332	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	5.02e-05	0.000331	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	4.9e-05	0.000323	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	4.81e-05	0.000317	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	4.81e-05	0.000317	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	4.79e-05	0.000316	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	4.71e-05	0.000311	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	4.7e-05	0.00031	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	4.55e-05	0.0003	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—GNB3—type 2 diabetes mellitus	4.51e-05	0.000298	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	4.45e-05	0.000294	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—AVP—type 2 diabetes mellitus	4.45e-05	0.000294	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—MMP3—type 2 diabetes mellitus	4.45e-05	0.000294	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—IGF2—type 2 diabetes mellitus	4.43e-05	0.000292	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—GNB3—type 2 diabetes mellitus	4.41e-05	0.000291	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	4.41e-05	0.000291	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	4.36e-05	0.000288	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—AVP—type 2 diabetes mellitus	4.35e-05	0.000287	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—MMP3—type 2 diabetes mellitus	4.35e-05	0.000287	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—IGF2—type 2 diabetes mellitus	4.33e-05	0.000286	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	4.31e-05	0.000285	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—APOB—type 2 diabetes mellitus	4.3e-05	0.000284	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	4.28e-05	0.000283	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	4.27e-05	0.000282	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—EDN1—type 2 diabetes mellitus	4.23e-05	0.000279	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—APOB—type 2 diabetes mellitus	4.21e-05	0.000278	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	4.19e-05	0.000276	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—EDN1—type 2 diabetes mellitus	4.14e-05	0.000273	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—LPL—type 2 diabetes mellitus	4.11e-05	0.000271	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	4.02e-05	0.000265	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—LPL—type 2 diabetes mellitus	4.02e-05	0.000265	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	3.93e-05	0.000259	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	3.85e-05	0.000254	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CCR5—type 2 diabetes mellitus	3.78e-05	0.00025	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	3.77e-05	0.000249	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CCR5—type 2 diabetes mellitus	3.7e-05	0.000244	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—C3—type 2 diabetes mellitus	3.7e-05	0.000244	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—C3—type 2 diabetes mellitus	3.62e-05	0.000239	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.53e-05	0.000233	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.52e-05	0.000232	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—AGT—type 2 diabetes mellitus	3.51e-05	0.000232	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.45e-05	0.000228	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.45e-05	0.000228	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—LEP—type 2 diabetes mellitus	3.44e-05	0.000227	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—APOE—type 2 diabetes mellitus	3.44e-05	0.000227	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.44e-05	0.000227	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—AGT—type 2 diabetes mellitus	3.44e-05	0.000227	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.4e-05	0.000224	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.38e-05	0.000223	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—APOE—type 2 diabetes mellitus	3.37e-05	0.000222	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—LEP—type 2 diabetes mellitus	3.37e-05	0.000222	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.33e-05	0.00022	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.25e-05	0.000214	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.17e-05	0.000209	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.07e-05	0.000203	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—IRS1—type 2 diabetes mellitus	3e-05	0.000198	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—INS—type 2 diabetes mellitus	2.94e-05	0.000194	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.89e-05	0.000191	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—INS—type 2 diabetes mellitus	2.88e-05	0.00019	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.84e-05	0.000188	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.84e-05	0.000188	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.83e-05	0.000187	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.83e-05	0.000187	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.78e-05	0.000184	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.78e-05	0.000183	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.77e-05	0.000183	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.7e-05	0.000178	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.64e-05	0.000174	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.58e-05	0.00017	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.58e-05	0.00017	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.52e-05	0.000166	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.52e-05	0.000166	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—RELA—type 2 diabetes mellitus	2.43e-05	0.00016	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—RELA—type 2 diabetes mellitus	2.37e-05	0.000157	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.21e-05	0.000146	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.19e-05	0.000144	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.17e-05	0.000143	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.16e-05	0.000143	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.14e-05	0.000141	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.13e-05	0.00014	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.07e-05	0.000136	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.05e-05	0.000135	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.02e-05	0.000134	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.01e-05	0.000132	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2e-05	0.000132	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.96e-05	0.00013	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.91e-05	0.000126	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—SRC—type 2 diabetes mellitus	1.87e-05	0.000123	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.86e-05	0.000123	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.82e-05	0.00012	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.7e-05	0.000112	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.67e-05	0.00011	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.67e-05	0.00011	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.64e-05	0.000108	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.28e-05	8.48e-05	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—IL6—type 2 diabetes mellitus	1.26e-05	8.29e-05	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.19e-05	7.82e-05	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.16e-05	7.65e-05	CbGpPWpGaD
